Status:
ACTIVE_NOT_RECRUITING
Patient Reported Outcomes Measures to Predict Pancreatic Surgery Outcomes
Lead Sponsor:
Massimo Falconi
Conditions:
Pancreatic Cancer
Patient Reported Outcome Measures
Eligibility:
All Genders
18+ years
Brief Summary
This is a prospective single-center observational study with the mail objective to identify specific subgroups of patients planned for pancreatic resection, at high risk for postoperative morbidity an...
Detailed Description
Patients undergoing pancreatic surgery, even treated in high-volume centers, still experience significant postoperative morbidity and full recovery after surgery takes longer than expected, delaying a...
Eligibility Criteria
Inclusion
- All adult patients (age \> 18 years) with pancreatic, biliary or duodenal diseases planned for pancreatic resection at San Raffaele Hospital
- Signed informed consent
Exclusion
- Patients with American Society of Anesthesiologists (ASA) health status class 4-5.
- Patients with co-morbid medical, physical and mental conditions (e.g. dementia, disabling orthopedic and neuromuscular disease, psychosis), cardiac abnormalities, severe end-organ disease such as cardiac failure, morbid obesity (BMI \>40), anemia (hematocrit \< 30 %) and other conditions interfering with the ability to complete the performance testing procedures.
- Inability to read or understand Italian.
Key Trial Info
Start Date :
May 7 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2024
Estimated Enrollment :
560 Patients enrolled
Trial Details
Trial ID
NCT04431076
Start Date
May 7 2020
End Date
June 30 2024
Last Update
January 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS San Raffaele
Milan, Italy, 20132